Today, the American Kidney Fund (AKF) and the IgA Nephropathy Foundation are on Capitol Hill with more than 80 advocates who are living with rare kidney diseases to urge elected officials to support ...
At 6, Los Angeles boy Dylan Siegel wrote and sold a book calledChocolate Barto help fund research into his best friend ...
While Jen McGowan describes her son as a “really happy baby,” she admits to PEOPLE that his younger years were “intense” ...
Frontotemporal dementia is still far less understood than Alzheimer's disease, which is why awareness weeks matter so much to ...
A 25-year-old living with Duchenne muscular dystrophy explains why the Senate confirmation fight over FDA nominee Dr. Heidi ...
Three of the nation's leading federal health officials will join more than 900 rare disease leaders across patient advocacy, industry, policy, science and medicine at the 2026 NORD® Rare Diseases and ...
Primary biliary cholangitis, or PBC, affects less than 1% of the population. Doctors do not know exactly what causes it, and ...
Canada’s rare disease diagnostic challenge cannot be solved by genomics and data alone; it requires investment in the people, expertise, and clinical systems needed to recognize rare diseases earlier ...
Today, the American Kidney Fund (AKF) is convening its seventh annual national summit on Unknown Causes of Kidney Disease (UCKD) in Washington, D.C., bringing healthcare professionals, researchers, ...
For people living with rare autoimmune blistering diseases, the daily reality extends far beyond the blisters themselves.
Over 55 million people worldwide are living with the devastating reality of dementia, but researchers have now identified ...
AS2Bio: MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug ...